ArticleCureus2025
Thyroid-Stimulating Hormone (TSH)-Secreting Pituitary Macroadenoma Presenting as Biochemical Hyperthyroidism Without Clinical Symptoms: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thyroid-stimulating hormone (TSH)-secreting pituitary adenomas (TSH-omas) are a rare cause of hyperthyroidism. We present a case of a 46-year-old male who was incidentally diagnosed with hyperthyroidism during an annual physical examination, with elevated TSH and free T4 consistent with central hyperthyroidism. Diagnosis of TSH-oma requires a combination of biochemical testing, including measurement of the alpha subunit and the alpha-subunit/TSH molar ratio, pituitary imaging, and differential diagnosis to exclude resistance to thyroid hormone (RTH). Further evaluation for the patient confirmed an elevated alpha subunit and a ratio supportive of TSH-oma. A pituitary MRI revealed a pituitary macroadenoma. Surgery is the primary treatment modality, and the patient underwent successful endoscopic endonasal removal of the pituitary macroadenoma. Postoperative biochemical testing six weeks after surgery showed normalization of thyroid function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.